Department of Medicinal Chemistry, Neurocrine Biosciences Inc., San Diego, CA 92130, USA. bdyck@neurocrine.com
Abstract:
A series of substituted chromones were designed, synthesized, and evaluated for their ability to bind melanin-concentrating hormone receptor 1. Compounds with subnanomolar binding affinity and 66% oral bioavailability in rats were discovered.